
What We're Reading: Pharma to Testify at Drug Pricing Hearing; Netflix Model for Hep C Drug; Marijuana and Other Drugs
At least 4 chief exeuctive officers from pharmaceutical companies will testify at a Senate drug pricing hearing later this month; Washington becomes the second state to try a subscription-based model for purchasing hepatitis C drugs; and data suggest that marijuana lowers use of alcohol and other drugs.
Pharma to Testify at Senate Drug Pricing Hearing
Chief executive officers from at least 4 drug makers will testify at a Senate hearing on prescription drug prices, with CEOs from Pfizer, Bristol-Myers Squibb, Sanofi, and Merck agreeing to testify later this month.
Washington Adopts Netflix Model for Hepatitis C Drug
In January, Louisiana became the first state to implement what’s being called a Netflix subscription model to buy hepatitis C drugs in order to cope with the cost of the treatments, and Washington has followed suit,
Marijuana Decreases Use of Alcohol, Other Prescription Drugs
Adding to data demonstrating that marijuana is associated with reduced use of opioids and opioid abuse,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.